ASX - By Stock
|
OSL |
Re:
Ann: First patient treated with OncoSil device in Turkiye
|
|
BlingSter
|
8 |
2.4K |
0 |
17/04/24 |
17/04/24 |
ASX - By Stock
|
8
|
2.4K
|
0
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
BlingSter
|
26 |
6.2K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
6.2K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Ann: UK Private Insurer Approves Reimbursement for OncoSil
|
|
BlingSter
|
26 |
6.2K |
2 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
26
|
6.2K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Next price sensitive announcement MSB
|
|
BlingSter
|
41 |
18K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
41
|
18K
|
1
|
|
ASX - By Stock
|
360 |
Re:
Ann: Market Update
|
|
BlingSter
|
50 |
14K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
50
|
14K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
BlingSter
|
601 |
232K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
601
|
232K
|
1
|
|
ASX - By Stock
|
AMP |
Re:
Ann: S&P ratings update
|
|
BlingSter
|
4 |
1.2K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
4
|
1.2K
|
0
|
|
ASX - By Stock
|
AMP |
Re:
What is the aim of the buyback?
|
|
BlingSter
|
99 |
19K |
0 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
99
|
19K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
How to Loan out shares on ASX??
|
|
BlingSter
|
30 |
8.8K |
6 |
01/04/24 |
01/04/24 |
ASX - By Stock
|
30
|
8.8K
|
6
|
|
ASX - By Stock
|
AMP |
Re:
What is the aim of the buyback?
|
|
BlingSter
|
99 |
19K |
0 |
31/03/24 |
31/03/24 |
ASX - By Stock
|
99
|
19K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
2024 Here we go again.
|
|
BlingSter
|
601 |
232K |
3 |
27/03/24 |
27/03/24 |
ASX - By Stock
|
601
|
232K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
BlingSter
|
551 |
202K |
8 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
202K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
BlingSter
|
85 |
22K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
85
|
22K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
BlingSter
|
551 |
202K |
13 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
202K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
BlingSter
|
226 |
78K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
78K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Cleansing Notice
|
|
BlingSter
|
3 |
1.9K |
1 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
3
|
1.9K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
BlingSter
|
226 |
78K |
14 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
78K
|
14
|
|
ASX - By Stock
|
MSB |
Re:
FDA meeting
|
|
BlingSter
|
1 |
800 |
4 |
22/03/24 |
22/03/24 |
ASX - By Stock
|
1
|
800
|
4
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
BlingSter
|
58 |
14K |
5 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
14K
|
5
|
|
ASX - By Stock
|
OSL |
Re:
News: OSL Oncosil Medical Seeks Trading Halt
|
|
BlingSter
|
58 |
14K |
2 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
58
|
14K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
8 |
18/03/24 |
18/03/24 |
ASX - By Stock
|
549
|
173K
|
8
|
|
ASX - By Stock
|
OSL |
Re:
Ann: Appendix 4D and Half Year Accounts
|
|
BlingSter
|
25 |
7.7K |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
25
|
7.7K
|
1
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
BlingSter
|
55 |
21K |
1 |
17/03/24 |
17/03/24 |
ASX - By Stock
|
55
|
21K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Placement and Entitlement Offer
|
|
BlingSter
|
154 |
46K |
2 |
14/03/24 |
14/03/24 |
ASX - By Stock
|
154
|
46K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
173K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
0 |
13/03/24 |
13/03/24 |
ASX - By Stock
|
549
|
173K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
1 |
12/03/24 |
12/03/24 |
ASX - By Stock
|
549
|
173K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
5 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
173K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Supports Accelerated Approval Pathway for Heart Failure
|
|
BlingSter
|
549 |
173K |
7 |
11/03/24 |
11/03/24 |
ASX - By Stock
|
549
|
173K
|
7
|
|
ASX - By Stock
|
360 |
Re:
US based equivalent valuation
|
|
BlingSter
|
6 |
3.7K |
4 |
04/03/24 |
04/03/24 |
ASX - By Stock
|
6
|
3.7K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Litigation Update
|
|
BlingSter
|
86 |
33K |
1 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
86
|
33K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Report and Accounts (including Appendix 4D)
|
|
BlingSter
|
31 |
9.5K |
8 |
01/03/24 |
01/03/24 |
ASX - By Stock
|
31
|
9.5K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Half Year Financial Results Presentation
|
|
BlingSter
|
78 |
24K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
78
|
24K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2024 Half Year Financial Results Webcast
|
|
BlingSter
|
62 |
23K |
9 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
62
|
23K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast 2024 Half Year Financial Results Webcast
|
|
BlingSter
|
62 |
23K |
2 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
62
|
23K
|
2
|
|
ASX - By Stock
|
OSL |
Re:
Why OSL is a Multi-Bagger
|
|
BlingSter
|
55 |
21K |
0 |
18/02/24 |
18/02/24 |
ASX - By Stock
|
55
|
21K
|
0
|
|
ASX - By Stock
|
OSL Biotech |
Re:
Time to go long big on $OSL?
|
|
BlingSter
|
17 |
7.1K |
1 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
17
|
7.1K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.6K |
2.8M |
8 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Orphan Drug Designation for Revascor
|
|
BlingSter
|
272 |
100K |
8 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
272
|
100K
|
8
|
|
ASX - By Stock
|
AMP |
Re:
Ann: Appendix 4E & 2023 Annual Report
|
|
BlingSter
|
91 |
24K |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
91
|
24K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.6K |
2.8M |
0 |
14/02/24 |
14/02/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ryoncil - potency assay data
|
|
BlingSter
|
15 |
5.1K |
0 |
06/02/24 |
06/02/24 |
ASX - By Stock
|
15
|
5.1K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.6K |
2.8M |
5 |
29/01/24 |
29/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
5
|
|
ASX - By Stock
|
AMP |
Re:
AMP Valuations - up to $2.17
|
|
BlingSter
|
124 |
32K |
0 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
124
|
32K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.6K |
2.8M |
4 |
08/01/24 |
08/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
BlingSter
|
9.6K |
2.8M |
8 |
06/01/24 |
06/01/24 |
ASX - By Stock
|
9.6K
|
2.8M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
124K |
2 |
03/01/24 |
03/01/24 |
ASX - By Stock
|
512
|
124K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
124K |
1 |
02/01/24 |
02/01/24 |
ASX - By Stock
|
512
|
124K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
124K |
3 |
01/01/24 |
01/01/24 |
ASX - By Stock
|
512
|
124K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Institutional Placement and Entitlement Offer
|
|
BlingSter
|
512 |
124K |
6 |
31/12/23 |
31/12/23 |
ASX - By Stock
|
512
|
124K
|
6
|
|